Silvant Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.04M	Buy	18,258 +294	+2%	+$100K	0.21%	57
2025 Q4	$7.14M	Buy	17,964 +288	+2%	+$127K	0.24%	48
2025 Q3	$8.06M	Sell	17,676 -1,671	-9%	-$680K	0.28%	45
2025 Q2	$6.31M	Buy	19,347 +3,152	+19%	+$872K	0.24%	57
2025 Q1	$4.37M	Hold	16,195	–	–	0.2%	64
2024 Q4	$3.81M	Hold	16,195	–	–	0.16%	81
2024 Q3	$4.45M	Buy	16,195 +2,534	+19%	+$660K	0.2%	68
2024 Q2	$3.32M	Hold	13,661	–	–	0.15%	93
2024 Q1	$2.04M	Hold	13,661	–	–	0.1%	120
2023 Q4	$2.61M	Hold	13,661	–	–	0.14%	96
2023 Q3	$2.42M	Hold	13,661	–	–	0.15%	95
2023 Q2	$2.59M	Hold	13,661	–	–	0.15%	97
2023 Q1	$2.74M	Hold	13,661	–	–	0.18%	92
2022 Q4	$3.25M	Buy	13,661 +3,522	+35%	+$751K	0.23%	84
2022 Q3	$2.03M	Buy	+10,139	New	+$1.93M	0.14%	106